Last reviewed · How we verify
NCT07185750
Investigation of Catastrophizing of Pain Reported by Parents in JIA Patients
trial testing Questionnaire application for JIA cases and their parents in Juvenile Idiopathic Arthritis (JIA) in 50 participants. Currently enrolling.
4 August 2026
Quick facts
| Lead sponsor | Hacettepe University |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 4 August 2025 |
| Primary completion | 4 August 2026 |
| Estimated completion | 4 August 2027 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Questionnaire application for JIA cases and their parents
Conditions studied
- Juvenile Idiopathic Arthritis (JIA) — all drugs for Juvenile Idiopathic Arthritis (JIA) →
- Childhood Rheumatic Diseases — all drugs for Childhood Rheumatic Diseases →
Sponsor
Hacettepe University
Who can join
Adults 7 to 18, any sex, with Juvenile Idiopathic Arthritis (JIA) or Childhood Rheumatic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Juvenile idiopathic arthritis (JIA) is the primary rheumatic disease reported to affect the pediatric population. Research suggests that parents' thoughts and feelings about their child's pain, specifically with JIA diagnosis, may influence treatment compliance. Considering that this situation may also affect children's adherence to treatment, the identification and management of parents' catastrophizing of pain is emphasized as important in improving treatment outcomes. This study aimed to examine the biopsychosocial characteristics of parents of children diagnosed with JIA according to their reported catastrophizing of pain.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07185750
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Juvenile Idiopathic Arthritis (JIA)
Currently open trials in the same condition.
- NCT07087912 — Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases · Phase 4 · recruiting
- NCT07234747 — Structured vs. Exergaming-Based Core Stabilization in Children With Juvenile Idiopathic Arthritis · NA · recruiting
- NCT06806774 — Reliability and Validity of the Glittre Activities of Daily Living Test in Children and Adolescents With Juvenile Idiopa · recruiting
- NCT06874608 — Evaluation of the Efficacy and Tolerability of an Exclusion Diet in Patients With Juvenile Idiopathic Arthritis · NA · recruiting
- NCT06862843 — Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic Immune-medi · recruiting
Other Hacettepe University trials
Trials by the same sponsor.
- NCT07522060 — Early Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Us · not yet recruiting
- NCT07390162 — The Effect of Changes in the Frequency of Endotracheal Tube Repositioning in Intensive Care Units on the Prevention of O · NA · not yet recruiting
- NCT07579676 — DEVELOPMENT AND PSYCHOMETRIC EVALUATION OF THE NEUROCOGNITIVE UPPER EXTREMITY TESTS: A RELIABILITY AND VALIDITY STUDY · not yet recruiting
- NCT07524842 — Clinical Performance of Three Different Restorative Materials · NA · not yet recruiting
- NCT07439861 — The Effect of Cognitive Dual-Task on Athletic Performance Parameters in Volleyball Players With and Without Chronic Ankl · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07185750 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hacettepe University
- Last refreshed: 22 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07185750.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing